AzTrials
AzTrials

Tooth LossIMPLA-CHANCT07801573

Immediate Molar Implants With Customized Healing Abutments in Different Post-Extraction Socket Classes

An observational study of Tooth Loss and Alveolar Bone Loss, run by Plovdiv Medical University at 1 site in Bulgaria.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Immediate implant placement into a fresh extraction socket shortens overall treatment time and reduces the number of surgical procedures, but the fit between the implant and the socket walls, and the resulting soft-tissue contour, differ substantially between socket types. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Immediate implant placement with customized healing abutment
Type of treatment
Surgery or procedure
How many people
60 participants
Where
1 siteBulgaria
Study dates
1 Apr 2024to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Consecutive adult patients attending the Department of Dental Implantology, Faculty of Dental Medicine, Medical University - Plovdiv, with a non-restorable posterior (premolar or molar) tooth indicated for extraction and suitable for immediate implant placement.

Who may be able to join

  • Age 18 years or over
  • ASA physical status I or II
  • A non-restorable posterior tooth (premolar or molar) indicated for extraction: clinically unrestorable crown, advanced chronic periodontitis, failed or untreatable endodontic therapy, or vertical root fracture
  • Residual bone permitting implant placement with adequate primary stability
  • Able and willing to give written informed consent and to attend the follow-up schedule

Who cannot join

  • ASA physical status III or higher
  • Pregnancy or lactation
  • Uncontrolled diabetes mellitus
  • Smoking more than 10 cigarettes per day
  • Drug or alcohol abuse
  • Current or previous bisphosphonate or other antiresorptive therapy
Show all 14Show fewer
  • Head and neck radiotherapy
  • Immunosuppression
  • Anticoagulant or antiplatelet therapy where the required pre-operative preparation is declined
  • Psychiatric conditions preventing compliance with the study procedures
  • Known titanium allergy
  • Severe bruxism
  • Acute infection at the surgical site
  • Advanced alveolar resorption precluding immediate implant placement

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lyubomir Chenchev, DMD, PhD contact

+359 887 102 516

lyubomir.chenchev@mu-plovdiv.bg

Bulgaria1 site, 1 recruiting
  • Department of Dental Implantology, Faculty of Dental Medicine, Medical University - Plovdiv

    Plovdiv, 4000

    Lyubomir Chenchev, DMD, PhD, +359 887 102 516, lyubomir.chenchev@mu-plovdiv.bg

    Recruiting

Other trials in Bulgaria

About this study

Official title: Evaluation of the Success of Immediate Implants in the Molar Region Using Individually Fabricated Healing Abutments (Sulcus Formers) in Different Classes of Post-Extraction Sockets: A Prospective Cohort Study

Immediate implant placement into a fresh extraction socket shortens overall treatment time and reduces the number of surgical procedures, but the fit between the implant and the socket walls, and the resulting soft-tissue contour, differ substantially between socket types. This study evaluates immediate implant placement in the molar and posterior region combined with an individually fabricated (customized) healing abutment, or sulcus former, that seals the socket and shapes the emergence profile from the day of surgery.

Consecutive patients with a non-restorable posterior tooth are treated with flapless atraumatic extraction, immediate implant placement, grafting of the residual gap, and a chairside customized healing abutment fabricated on a titanium temporary abutment. Participants are grouped by the class of the post-extraction socket (A, B or C) according to the interradicular septal bone available for primary stability.

Outcomes are preservation of peri-implant soft-tissue volume assessed with an intraoral scanner, preservation of alveolar bone volume assessed on cone-beam computed tomography, implant stability measured by resonance frequency analysis (ISQ) at placement and before loading, and time to definitive loading. Early wound healing on the Landry index, the degree of bone corticalization before loading, implant survival, healing-abutment complications and analgesic requirement are also recorded.

Being tested
Immediate implant placement with customized healing abutment
Keywords
immediate implant placement, customized healing abutment, sulcus former, post-extraction socket, socket classification, molar, implant stability quotient, cone-beam computed tomography, peri-implant soft tissue, emergence profile
Medical subject headings
Tooth Loss, Alveolar Bone Loss, Jaw, Edentulous, Partially

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Immediate implant placement with customized healing abutmentProcedure or surgery

    Flapless atraumatic extraction with tooth sectioning and root-by-root removal, socket debridement and saline irrigation, followed by immediate placement of a MegaGen AnyRidge implant (MegaGen Implant Co., Daegu, South Korea; diameter 4.0-5.5 mm, length 8.5-11.5 mm) in a subcrestal position at the level of the septal bone. Where insertion torque of at least 35 Ncm and an implant stability quotient of at least 65 are achieved, the residual gap is grafted with equine-derived xenograft granules of 0.25 mm (Maggi Biotechnology, Andezeno, Italy) and a customized healing abutment is fabricated chairside from flowable composite on a titanium temporary abutment (Spider Web technique), hand-tightened and left free of occlusal contact. No barrier membrane is used. Definitive loading is planned at three months.

Study groups in NCT07801573
Study groupRoleWhat they receive
Socket class APosterior extraction socket in which the interradicular septal bone is sufficient to house the implant, giving circumferential bone contact along its coronal part. Because a molar socket is frequently 10 mm or more across, a residual void commonly remains around the implant within the socket. Participants receive immediate implant placement with a chairside customized healing abutment.
Receives: Procedure: Immediate implant placement with customized healing abutment
Socket class BPosterior extraction socket in which the septal bone is sufficient to stabilise the implant but not to house it, so that part of the implant surface faces the socket rather than bone. Participants receive immediate implant placement with a chairside customized healing abutment.
Receives: Procedure: Immediate implant placement with customized healing abutment
Socket class CPosterior extraction socket with little or no septal bone, so that primary stability must be obtained from the peripheral socket walls and/or the bone apical to the socket. Participants receive immediate implant placement with a chairside customized healing abutment.
Receives: Procedure: Immediate implant placement with customized healing abutment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in peri-implant soft-tissue volume

    Volumetric change of the peri-implant soft tissue relative to the pre-extraction baseline, measured in cubic millimetres by superimposition of intraoral scans.

    Measured: Baseline, 3 months after placement (before loading), and 2 weeks after loading

  2. Time to definitive loading

    Interval in months from implant placement to definitive prosthetic loading, determined by the pre-loading radiographic assessment and the implant stability quotient.

    Measured: Up to 6 months after implant placement

  3. Implant stability quotient (ISQ)

    Implant stability measured by resonance frequency analysis on the ISQ scale from 1 to 100, where higher values indicate greater stability. Stability before loading is the criterion that determines whether the implant is loaded at three months.

    Measured: At implant placement and at 3 months after placement (before loading)

  4. Change in alveolar bone volume

    Volumetric change of the peri-implant alveolar bone relative to the pre-extraction baseline, measured in cubic millimetres on cone-beam computed tomography.

    Measured: Baseline and 3 months after placement (before loading)

Secondary outcomes (5)
  1. Early wound healing

    Early wound healing graded on the Landry Wound Healing Index from 1 to 5, where higher values indicate better healing.

    Measured: Days 7 and 14 after surgery

  2. Analgesic requirement

    Number of participants taking the prescribed analgesic (ibuprofen L-arginine 600 mg twice daily as needed) after surgery.

    Measured: First 5 days after surgery

  3. Customized healing abutment complications

    Number of participants with abutment screw loosening, fracture of the composite healing abutment, or peri-implant infection, each recorded as present or absent.

    Measured: From surgery to definitive loading, up to 4 months

  4. Implant survival

    Proportion of implants in situ and functional at the latest follow-up visit.

    Measured: Up to 24 months after implant placement

  5. Peri-implant bone corticalization

    Degree of corticalization of the peri-implant bone, assessed on cone-beam computed tomography using a radiological corticalization index.

    Measured: 3 months after placement (before loading)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2026
  2. Study start1 Apr 2024
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07801573
Sponsor's protocol ID
NO-18/2025
Other IDs
R-KNE-55/10.11.2025
Acronym
IMPLA-CHA
Status last verified
Aug 2026
First submitted
31 Aug 2026
Last updated
3 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made publicly available. De-identified data supporting the published analyses are available from the corresponding author on reasonable request.

Questions about this trial

What is this clinical trial studying?

An observational study of Tooth Loss and Alveolar Bone Loss, run by Plovdiv Medical University at 1 site in Bulgaria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Bulgaria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lyubomir Chenchev, DMD, PhD (+359 887 102 516, lyubomir.chenchev@mu-plovdiv.bg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in peri-implant soft-tissue volume (time frame: Baseline, 3 months after placement (before loading), and 2 weeks after loading). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in